Answers are grounded in this paper and cite their sources.
The overall incidence of febrile neutropenia and severe infectious complications in children with cancer is low, with differences according to the aggressiveness of chemotherapy. This fact must be considered when designing clinical trials on the management of infectious complications in children with cancer.
No takes yet. Share an insight, caveat, or question.
Castagnola et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: